Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): Protocol for a randomised controlled trial

Trials

Volumn 15, Issue 1, 2014, Pages

  Webb, Nicholas J A ^a,q   Frew, Emma ^b   Brettell, Elizabeth A ^b   Milford, David V ^c,q   Bockenhauer, Detlef ^d,q   Saleem, Moin A ^e,q   Christian, Martin ^f,q   Hall, Angela S ^g,q   Koziell, Ania ^h,q   Maxwell, Heather ^i,q   Hegde, Shivram ^j,q   Finlay, Eric R ^k,q   Gilbert, Rodney D ^l,q   Booth, Jenny ^m,q   Jones, Caroline ^n,q   McKeever, Karl ^o,q   Cook, Wendy ^p,q   Ives, Natalie J ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^g UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^h EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

ⁱ ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^j UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^k Leeds Children's Hospital   (United Kingdom)

^l UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^m Newcastle Upon Tyne Hospitals NHS Foundation Trust   (United Kingdom)

ⁿ ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^o ROYAL BELFAST HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^p Nephrotic Syndrome Trust   (United Kingdom)

^q The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

more..

Author keywords

Adverse effects; Health economic analysis; Prednisolone; Relapse; Steroid sensitive nephrotic syndrome; Upper respiratory tract infection

Indexed keywords

AZATHIOPRINE; BROMOPHENOL BLUE; CYCLOSPORIN A; DNA; LEVAMISOLE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISOLONE; RNA; TACROLIMUS; GLUCOCORTICOID;

ARTICLE; CHILD BEHAVIOR; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ECONOMIC EVALUATION; FOLLOW UP; HEALTH ECONOMICS; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; NEPHROTIC SYNDROME; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SHORT COURSE THERAPY; STEROID SENSITIVE NEPHROTIC SYNDROME; TREATMENT DURATION; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; ADOLESCENT; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG ADMINISTRATION; DRUG COST; ECONOMICS; METHODOLOGY; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; RECURRENT DISEASE; RESPIRATORY TRACT INFECTIONS; TIME; YOUNG ADULT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; GLUCOCORTICOIDS; HUMANS; NEPHROTIC SYNDROME; PREDNISOLONE; RECURRENCE; RESEARCH DESIGN; RESPIRATORY TRACT INFECTIONS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901283605     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-147     Document Type: Article

References (14)

1. McKinney PA, Feltblower RG, Brocklebank JT, Fitzpatrick MM. Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol 2001, 15:1040-1044.
2. Trompeter RS, Lloyd BW, Hicks J, White RH, Cameron JS. Long-term outcome for children with minimal change nephrotic syndrome. Lancet 1985, 1:368-370.
3. Shenoy M, Plant ND, Lewis MA, Bradbury MG, Lennon R, Webb NJ. Intravenous methylprednisolone in idiopathic childhood nephrotic syndrome. Pediatr Nephrol 2010, 25(5):899-903. 10.1007/s00467-009-1417-1, 20108003.
4. International Study of Kidney Disease in Children Nephrotic syndrome in children: a randomised controlled trial comparing two prednisone regimens in steroid-responsive patients who relapse early. J Pediatr 1982, 95:239-243. International Study of Kidney Disease in Children.
5. Webb NJA. Epidemiology and general management of childhood idiopathic nephrotic syndrome. Evidence-based Nephrology 2008, Oxford, UK: Wiley-Blackwell, Molony D, Craig J.
6. Hall AS, Thorley G, Houtman PN. The effects of corticosteroids on behaviour in children with nephrotic syndrome. Pediatr Nephrol 2003, 18(12):1220-1223. 10.1007/s00467-003-1295-x, 14577022.
7. MacDonald N, Wolfish N, McLaine P, Phipps P, Rossier E. Role of respiratory viruses in exacerbations of primary nephrotic syndrome. J Paediatr 1986, 108:378-382.
8. Mattoo TK, Mahmoud MA. Increased maintenance corticosteroids during upper respiratory infection decrease the risk of relapse in nephrotic syndrome. Nephron 2000, 85:343-345. 10.1159/000045684, 10940745.
9. Abeyagunawardena AS, Trompeter RS. Increasing the dose of prednisolone during viral infection reduced the risk of relapse in nephrotic syndrome: a randomised controlled trial. Arch Dis Child 2008, 93:226-228. 10.1136/adc.2007.116079, 17573408.
10. Gulati A, Sinha A, Sreenivas V, Math A, Hari P, Bagga A. Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomised controlled trial. Clin J Am Soc Nephrol 2011, 6:63-69. 10.2215/CJN.01850310, 3022249, 20847092.
11. Machin D, Campbell MJ, Tan SB, Tan SH. Sample Size Tables for Clinical Studies 2009, Chichester: Wiley-Blackwell, 3.
12. Schulz KF, Altman DG, Moher D. CONSORT Group: CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:C332. 10.1136/bmj.c332, 2844940, 20332509.
13. Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Götzsche PC, Krleža-Jerić K, Hróbjartsson A, Mann H, Dickersin K, Berlin JA, Doré CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013, 158:200-207. 10.7326/0003-4819-158-3-201302050-00583, 23295957.
14. PREDNOS 2. [http://www.birmingham.ac.uk/prednos2].